Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma

NCT02391662 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Carcinoma Metastatic

Interventions

DRUG: Nab-paclitaxel 125 mg/m2 weeks 1,2,3/4
DRUG: Gemcitabine 1000 weeks 1,2,3/4

Sponsor

Asociación de Oncología Médica del Hospital de Cruces

Collaborators

[object Object]
[object Object]